PCSA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Processa Pharmaceuticals Inc (PCSA) is not a good buy for a beginner, long-term investor at this time. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals to suggest a compelling entry point. Additionally, technical indicators suggest bearish momentum, and there is no recent news or analyst activity to support a bullish outlook.
The MACD is slightly positive, indicating mild bullish momentum, but the RSI is neutral at 34.233. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels, with support at $2.126 and resistance at $2.531. Overall, the technical setup suggests bearish momentum.
NULL identified. No recent news, no significant hedge fund or insider activity, and no congress trading data.
and a significant drop in EPS (-92.99% YoY). The stock also has bearish technical indicators and lacks trading signals.
In Q3 2025, revenue remained at $0 with no growth YoY. Net income slightly improved by 1.53% YoY but remains negative at -$3,436,573. EPS dropped significantly by -92.99% YoY to -1.81, reflecting poor profitability. Gross margin remains at 0%.
No recent analyst ratings or price target changes available.
